Natalizumab is associated with early improvement of working ability in relapsing-remitting multiple sclerosis patients: WANT observational study results
Ruggero Capra, Vincenzo Brescia Morra, Massimiliano Mirabella, Claudio Gasperini, Cinzia Scandellari, Rocco Totaro, Nicola De Rossi, Silvia Masera, Valentina Zipoli, Francesco Patti, on behalf of the WANT Investigators
Abstract